Chemotherapy-induced-peripheral neuropathy, gait and fall risk in older adults following cancer treatment

Chemotherapy-induced-peripheral neuropathy, gait and fall risk in older adults following cancer treatment

Background: Cancer patients undergoing chemotherapy often experience chemotherapy-induced peripheral neuropathy (CIPN), which reportedly causes gait disturbances that may increase their risk for falls. The purpose of this study was to investigate whether CIPN is associated with spatial-temporal gait...

Full description

Bibliographic Details
Main Authors:	Timothy F. Marshall, Genevieve Pinto Zipp, Fortunato Battaglia, Rebecca Moss, Stephanie Bryan
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2017-12-01
Series:	Journal of Cancer Research and Practice
Subjects:	Cancer Chemotherapy Peripheral neuropathy Falls Gait
Online Access:	http://www.sciencedirect.com/science/article/pii/S2311300616301975

Similar Items

A HOME-BASED EXERCISE PROGRAM TO IMPROVE NEUROMUSCULAR AND SPATIO-TEMPORAL GAIT PARAMETERS IN A MULTIPLE MYELOMA CANCER SURVIVOR WITH CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY: A CASE REPORT
by: Timothy F. Marshall, et al.
Published: (2019-08-01)

Falls and Functional Impairments in Breast Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy
by: Hiroko Komatsu, et al.
Published: (2019-01-01)

Assessment of Fall-Related Self-Efficacy: Characteristics that Influence the Perception of Patients with Chemotherapy-Induced Peripheral Neuropathy
by: Sena Yamamoto, et al.
Published: (2020-01-01)

The Effects of a Wearable Sensory Prosthesis on Gait and Balance Function After 10 Weeks of Use in Persons With Peripheral Neuropathy and High Fall Risk – The walk2Wellness Trial
by: Lars I. E. Oddsson, et al.
Published: (2020-11-01)

Extended effects of a wearable sensory prosthesis on gait, balance function and falls after 26 weeks of use in persons with peripheral neuropathy and high fall risk—The walk2Wellness trial
by: Lars I. E. Oddsson, et al.
Published: (2022-09-01)

Rehabilitation Interventions for Gait Problems in Patients With Diabetic Peripheral Neuropathy: A Scoping Review
by: Charles Philip Gabel, et al.
Published: (2020-10-01)

Gait analysis in chemotherapy-induced peripheral neurotoxicity rodent models
by: Maria Lopez-Garzon, et al.
Published: (2023-10-01)

The Future of Chemotherapy: The Mechanisms and Benefits of Exercise in Taxane-Induced Peripheral Neuropathy
by: Sumedha Shastry, et al.
Published: (2023-11-01)

Treatment strategies for chemotherapy-induced peripheral neuropathy: potential role of exercise
by: Karen Y. Wonders, et al.
Published: (2011-12-01)

Does the Presence of Cognitive Impairment Exacerbate the Risk of Falls in People with Peripheral Neuropathy? An Application of Body-Worn Inertial Sensors to Measure Gait Variability
by: Gu Eon Kang, et al.
Published: (2020-02-01)

A Systematic Review of Nutritional Lab Correlates with Chemotherapy Induced Peripheral Neuropathy
by: Cindy Tofthagen, et al.
Published: (2022-01-01)

Addressing Chemotherapy-Induced Peripheral Neuropathy Using Multi-Frequency Vibrometry and Patient-Reported Outcomes
by: Sebastian W. Nielsen, et al.
Published: (2022-03-01)

Targeting drug transporters to prevent chemotherapy-induced peripheral neuropathy
by: Kevin M. Huang, et al.
Published: (2021-01-01)

Efficacy of exercise on balance, fear of falling, and risk of falls in patients with diabetic peripheral neuropathy: a systematic review and meta-analysis
by: Renata Aparecida de Oliveira Lima, et al.
Published: (2021-03-01)

Editorial: Cognitive Impairment and Peripheral Neuropathy From Chemotherapy: Molecular Mechanisms and Therapeutic Approaches
by: Bojana Milutinovic, et al.
Published: (2022-07-01)

Therapeutic Effects of Phytochemicals and Medicinal Herbs on Chemotherapy-Induced Peripheral Neuropathy
by: Gihyun Lee, et al.
Published: (2016-09-01)

Balance training in the intervention of fall risk in elderly with diabetic peripheral neuropathy: A review
by: Xi Pan, et al.
Published: (2014-12-01)

Animal models of chemotherapy‐induced peripheral neuropathy for hematological malignancies: A review
by: Xiaoli Lv, et al.
Published: (2023-03-01)

Chemotherapy-Induced Peripheral Neuropathy and Physiotherapy
by: Gro S. Haugen, et al.
Published: (2013-04-01)

Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
by: Alex Molassiotis, et al.
Published: (2019-06-01)

Flavonoids Alleviate Peripheral Neuropathy Induced by Anticancer Drugs
by: Manaal Siddiqui, et al.
Published: (2021-03-01)

Non-Pharmacological Self-Management Strategies for Chemotherapy-Induced Peripheral Neuropathy in People with Advanced Cancer: A Systematic Review and Meta-Analysis
by: Megan Crichton, et al.
Published: (2022-06-01)

Dietary Supplements in Chemotherapy-Induced Peripheral Neuropathy: A New Hope?
by: Katarzyna Szklener, et al.
Published: (2022-01-01)

Physiotherapy management of chemotherapy-induced peripheral neuropathy in Pretoria, South Africa
by: Esther A. Niemand, et al.
Published: (2020-10-01)

Oxidative stress and nerve damage: Role in chemotherapy induced peripheral neuropathy
by: Aparna Areti, et al.
Published: (2014-01-01)

Regulatable Transgene Expression for Prevention of Chemotherapy-Induced Peripheral Neuropathy
by: Daisuke Kawata, et al.
Published: (2017-09-01)

Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients
by: Mitsuru Sugimoto, et al.
Published: (2021-12-01)

Characteristics and Quality of Life in Gynecologic Cancer Patients with Chemotherapy-induced Peripheral Neuropathy
by: Ju Hyeon Jeong, et al.
Published: (2013-12-01)

Chemotherapy induced peripheral neuropathic pain
by: Hue Jung Park
Published: (2014-07-01)

The Evaluation of Gait and Balance for Patients with Early Diabetic Peripheral Neuropathy: A Cross-Sectional Study
by: Jiang X, et al.
Published: (2022-03-01)

Neuroinflammation and сhemotherapy-induced peripheral neuropathy
by: P. I. Pilipenko, et al.
Published: (2022-04-01)

Assessing gait, balance, and muscle strength among breast cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): study protocol for a randomized controlled clinical trial
by: Patricia Teran-Wodzinski, et al.
Published: (2022-04-01)

Whole-body vibration as a modality for the rehabilitation of peripheral neuropathies: implications for cancer survivors suffering from chemotherapy-induced peripheral neuropathy
by: Anna L.J. Verhulst, et al.
Published: (2015-02-01)

Emerging Pharmacological and Non-Pharmacological Therapeutics for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy
by: Yang Li, et al.
Published: (2021-02-01)

Beneficial effects of exercise on chemotherapy-induced peripheral neuropathy and sleep disturbance: A review of literature and proposed mechanisms
by: L. Brett Whalen, et al.
Published: (2022-02-01)

The Role of Nucleotide Excision Repair in Cisplatin-Induced Peripheral Neuropathy: Mechanism, Prevention, and Treatment
by: Scarlett Acklin, et al.
Published: (2021-02-01)

Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study)
by: Sonoko Misawa, et al.
Published: (2023-11-01)

The Efficacy of Neuromodulation Interventions for Chemotherapy-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis
by: Xu R, et al.
Published: (2024-04-01)

Lithium and preventing chemotherapy-induced peripheral neuropathy in breast cancer patients: a placebo-controlled randomized clinical trial
by: S. Najafi, et al.
Published: (2021-11-01)

Comparative Efficacy of Tapentadol versus Tapentadol Plus Duloxetine in Patients with Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Randomized Non-Inferiority Clinical Trial
by: Pasquale Sansone, et al.
Published: (2022-08-01)